ciprofloxacin has been researched along with Endocarditis, Bacterial in 98 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Endocarditis, Bacterial: Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin has been studied extensively in discriminative animal models of infection, and its efficacy in the treatment of these infections has been compared with that of standard therapy." | 5.27 | Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. ( Brooks-Fournier, RA; Gerberding, JL; Sande, MA, 1987) |
| "We describe a 66-year-old woman with infective endocarditis due to Cardiobacterium hominis whose condition, complicated by severe aortic regurgitation and congestive heart failure, necessitated aortic valve replacement despite treatment with ceftriaxone followed by ciprofloxacin." | 3.70 | Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. ( Hsueh, PR; Hung, CC; Jang, TN; Lu, PL; Luh, KT; Teng, LJ, 2000) |
| " Antibiotic dosing was adjusted for renal dysfunction." | 2.68 | Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. ( Daoud, EG; Flexner, C; Goodman, SN; Hartert, TV; Heldman, AW; Kowalski, TE; Lietman, PS; Petty, BG; Pompili, VJ; Ray, SC; Sisson, SD; Tidmore, WC; vom Eigen, KA, 1996) |
| "The diagnosis of Q fever should be considered in cases of fever of unknown origin, especially if the subject has been in contact with mammals suspicious to be infected." | 2.46 | [Infection by Coxiella burnetii (Q fever)]. ( Collado, CM; Fariñas, MT, 2010) |
| "This patient's refusal of parenteral therapy prompted the use of oral ciprofloxacin because it is well absorbed and was expected to be very active against his organism." | 1.40 | Successful oral ciprofloxacin therapy of Neisseria elongata endocarditis. ( Herbert, DA, 2014) |
| "Then ciprofloxacin-treated and untreated constructs were implanted subcutaneously on the dorsum of rats and inoculated with Staphylococcus aureus." | 1.33 | In vivo testing of an infection-resistant annuloplasty ring. ( Andersen, ND; Bide, MJ; Contreras, MA; Dempsey, DJ; Hamdan, AD; LoGerfo, FW; Mitchell, RN; Monahan, TS; Phaneuf, MD; Popescu-Vladimir, A, 2006) |
| "Brucellosis is a multisystemic disease." | 1.32 | A case of mitral stenosis complicated with seronegative Brucella endocarditis. ( Ibrisim, E; Kutsal, A; Ocal, A; Ozaydin, M; Ulusan, V; Yavuz, T, 2004) |
| "Severe thrombocytopenia is a life-threatening condition." | 1.32 | Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. ( Arnold, DM; Christjanson, L; Smaill, F; Walker, I; Warkentin, TE, 2004) |
| "The diagnosis of deep seated bacterial infections, such as intra-abdominal abscesses, endocarditis, and osteomyelitis, can be difficult and delayed, thereby compromising effective treatment." | 1.31 | Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). ( Amaral, H; Bhatnagar, A; Britton, KE; Das, SS; Katamihardja, AH; Malamitsi, J; Moustafa, HM; Padhy, AK; Solanki, KK; Soroa, VE; Sundram, FX; Wareham, DW, 2002) |
| "Ciprofloxacin was studied against MSSA1199 and MSSA487." | 1.31 | Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations. ( Coyle, EA; Hershberger, E; Kaatz, GW; Rybak, MJ; Zervos, MJ, 2000) |
| "Moxifloxacin treatment resulted in culture-negative vegetations in a total of 20 of 21 (95%) rats infected with P8, 10 of 11 (91%) rats infected with COL, and 19 of 24 (79%) rats infected with P8-4 (P < 0." | 1.31 | Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. ( Entenza, JM; Glauser, MP; Moreillon, P; Que, YA; Vouillamoz, J, 2001) |
| "Treatment with ciprofloxacin was ineffective." | 1.30 | Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis. ( Entenza, JM; Glauser, MP; Marchetti, O; Moreillon, P, 1998) |
| "Trovafloxacin was more effective than vancomycin (CFU/g of vegetation, 2." | 1.30 | Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus. ( Chambers, HF; Chow, LL; Kim, YS; Liu, Q; Täuber, MG, 1998) |
| "Levofloxacin was investigated against viridans group streptococci in vitro and in rats with experimental aortic endocarditis." | 1.30 | Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. ( Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P, 1999) |
| "The in vivo efficacy of ciprofloxacin or pefloxacin alone or in combination with fosfomycin was evaluated in experimental aortic valve endocarditis induced in 133 rabbits by a multidrug-susceptible or multidrug-resistant strain of Pseudomonas aeruginosa." | 1.29 | Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa. ( Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Jehl, F; Le Conte, P; Potel, G; Stephant, G; Xiong, YQ, 1995) |
| "Ciprofloxacin was administered orally in order to suppress bacteremia for 36 months." | 1.28 | Long-term oral ciprofloxacin in the treatment of prosthetic valve endocarditis due to Pseudomonas aeruginosa. ( Akalin, HE; Demircin, M; Ugurlu, B; Unal, S; Uzun, O; Yorgancioglu, AC, 1992) |
| "Ciprofloxacin was as effective as beta-lactam-tobramycin combinations." | 1.28 | Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains. ( Bangsborg, J; Frimodt-Møller, N; Gutschik, E; Westh, H, 1992) |
| "Relapse is common even after apparently adequate therapy and may be seen in up to 25% of cases that involve streptomycin-resistant strains." | 1.28 | Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy. ( Dietrich, KA; Dixon, WA; Landau, SW; Miller, WC; Sacher, HL; Sacher, ML, 1991) |
| "Ciprofloxacin or rifampin was significantly (P less than 0." | 1.28 | Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. ( Henry, NK; Rouse, MS; Steckelberg, JM; Wilcox, RM; Wilson, WR, 1990) |
| " The dose, dosing interval, and duration of therapy were varied, and the resulting antibiotic levels in serum and vegetations were correlated with bacterial clearance from vegetations." | 1.27 | The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat. ( Ingerman, MJ; Levison, ME; Pitsakis, PG; Rosenberg, AF, 1986) |
| "Ciprofloxacin was more effective (P less than 0." | 1.27 | Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. ( Fernandez-Guerrero, M; Henry, N; Rouse, M; Wilson, W, 1988) |
| "No ciprofloxacin resistance was detected among Pseudomonas isolates from cardiac vegetations." | 1.27 | Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production. ( Bayer, AS; Blomquist, IK; Hirano, L; Lee, D; Lindsay, P; Yih, J, 1986) |
| "Ciprofloxacin has been studied extensively in discriminative animal models of infection, and its efficacy in the treatment of these infections has been compared with that of standard therapy." | 1.27 | Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. ( Brooks-Fournier, RA; Gerberding, JL; Sande, MA, 1987) |
| "The efficacy of a 5-day treatment with coumermycin A1 (hereafter referred to as coumermycin) (at three dosage regimens), with ciprofloxacin, or with coumermycin plus ciprofloxacin was tested in experimental aortic valve endocarditis induced in rats by a strain of methicillin-susceptible Staphylococcus aureus and was compared with the efficacy of a 5-day treatment with cloxacillin plus gentamicin." | 1.27 | Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination. ( Glauser, MP; Malinverni, R; Perronne, CM, 1987) |
| " This finding was likely due to changes in the pharmacokinetics of the drug with multiple dosing and in infected versus uninfected rabbits." | 1.27 | Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis. ( Barriere, SL; Fekety, R; Kaatz, GW; Schaberg, DR, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (20.41) | 18.7374 |
| 1990's | 41 (41.84) | 18.2507 |
| 2000's | 27 (27.55) | 29.6817 |
| 2010's | 10 (10.20) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiyangoda, CGK | 1 |
| Wimalaratna, H | 1 |
| Bowatte, S | 1 |
| Olivier, V | 1 |
| Brière, M | 1 |
| Bouillot, P | 1 |
| Sotto, A | 1 |
| Lechiche, C | 1 |
| Herbert, DA | 1 |
| Rossmann, FS | 1 |
| Racek, T | 1 |
| Wobser, D | 1 |
| Puchalka, J | 1 |
| Rabener, EM | 1 |
| Reiger, M | 1 |
| Hendrickx, AP | 1 |
| Diederich, AK | 1 |
| Jung, K | 1 |
| Klein, C | 1 |
| Huebner, J | 1 |
| Le Bourgeois, F | 1 |
| Germanaud, D | 1 |
| Bendavid, M | 1 |
| Bonnefoy, R | 1 |
| Desnous, B | 1 |
| Beyler, C | 1 |
| Blauwblomme, T | 1 |
| Elmaleh, M | 1 |
| Pierron, C | 1 |
| Lorrot, M | 1 |
| Bonacorsi, S | 1 |
| Basmaci, R | 1 |
| Jenkins, JM | 1 |
| Fife, A | 1 |
| Baghai, M | 1 |
| Dworakowski, R | 1 |
| Kuretski, J | 1 |
| Dahya, V | 1 |
| Cason, L | 1 |
| Chalasani, P | 1 |
| Ramgopal, M | 1 |
| Naba, MR | 1 |
| Araj, GF | 1 |
| Kanafani, ZA | 1 |
| Kanj, SS | 1 |
| Lim, IW | 1 |
| Stride, PJ | 1 |
| Horvath, RL | 1 |
| Hamilton-Craig, CR | 1 |
| Chau, PP | 1 |
| Allison, MC | 1 |
| Sandoe, JA | 1 |
| Tighe, R | 1 |
| Simpson, IA | 1 |
| Hall, RJ | 1 |
| Elliott, TS | 1 |
| Tsugawa, Y | 1 |
| Futatsuyama, M | 1 |
| Furukawa, K | 1 |
| Taki, F | 1 |
| Nishizaki, Y | 1 |
| Tamagaki, K | 1 |
| Kaneshiro, Y | 1 |
| Komatsu, Y | 1 |
| Pearson, RN | 1 |
| Fariñas, MT | 1 |
| Collado, CM | 1 |
| Joskowiak, D | 1 |
| Kappert, U | 1 |
| Matschke, K | 1 |
| Tugtekin, SM | 1 |
| Zekanović, D | 1 |
| Morović, M | 1 |
| Borcilo, MN | 1 |
| Rode, OD | 1 |
| Kunin, M | 1 |
| Salamon, F | 1 |
| Weinberger, M | 1 |
| Genkin, I | 1 |
| Sagie, A | 1 |
| Tur-Kaspa, R | 1 |
| Ebnöther, C | 1 |
| Altwegg, M | 1 |
| Gottschalk, J | 1 |
| Seebach, JD | 1 |
| Kronenberg, A | 1 |
| Britton, KE | 1 |
| Wareham, DW | 1 |
| Das, SS | 2 |
| Solanki, KK | 1 |
| Amaral, H | 1 |
| Bhatnagar, A | 1 |
| Katamihardja, AH | 1 |
| Malamitsi, J | 1 |
| Moustafa, HM | 1 |
| Soroa, VE | 1 |
| Sundram, FX | 1 |
| Padhy, AK | 1 |
| Entenza, JM | 5 |
| Vouillamoz, J | 3 |
| Glauser, MP | 6 |
| Moreillon, P | 5 |
| Sorabjee, JS | 1 |
| Garje, RR | 1 |
| Yavuz, T | 1 |
| Ozaydin, M | 1 |
| Ulusan, V | 1 |
| Ocal, A | 1 |
| Ibrisim, E | 1 |
| Kutsal, A | 1 |
| Arnold, DM | 1 |
| Smaill, F | 1 |
| Warkentin, TE | 1 |
| Christjanson, L | 1 |
| Walker, I | 1 |
| Mai, T | 1 |
| Mouly, S | 1 |
| Jarrin, I | 1 |
| Mahé, I | 1 |
| Sellier, P | 1 |
| Bergmann, JF | 1 |
| Monahan, TS | 1 |
| Phaneuf, MD | 1 |
| Contreras, MA | 1 |
| Andersen, ND | 1 |
| Popescu-Vladimir, A | 1 |
| Bide, MJ | 1 |
| Dempsey, DJ | 1 |
| Mitchell, RN | 1 |
| Hamdan, AD | 1 |
| LoGerfo, FW | 1 |
| Oteo, JA | 1 |
| Castilla, A | 1 |
| Arosey, A | 1 |
| Blanco, JR | 1 |
| Ibarra, V | 1 |
| Morano, LE | 1 |
| Zimhony, O | 1 |
| Chmelnitsky, I | 1 |
| Bardenstein, R | 1 |
| Goland, S | 1 |
| Hammer Muntz, O | 1 |
| Navon Venezia, S | 1 |
| Carmeli, Y | 1 |
| Patel, SM | 1 |
| Saravolatz, LD | 1 |
| O'Sullivan, CE | 1 |
| Starakis, I | 1 |
| Siagris, D | 1 |
| Karatza, C | 1 |
| Solomou, H | 1 |
| Bassaris, H | 1 |
| Quale, JM | 2 |
| Landman, D | 2 |
| Mobarakai, N | 2 |
| Bíró, L | 1 |
| Lengyel, M | 1 |
| Koltai, M | 1 |
| Hodics, T | 1 |
| Lee, PY | 1 |
| Xiong, YQ | 3 |
| Potel, G | 3 |
| Caillon, J | 3 |
| Stephant, G | 1 |
| Jehl, F | 1 |
| Bugnon, D | 3 |
| Le Conte, P | 2 |
| Baron, D | 2 |
| Drugeon, H | 1 |
| Conte, PL | 1 |
| Drugeon, HB | 2 |
| Vogt, K | 1 |
| Klefisch, F | 1 |
| Hahn, H | 1 |
| Schmutzler, H | 1 |
| Körner, RJ | 2 |
| Nicol, A | 1 |
| Reeves, DS | 2 |
| MacGowan, AP | 2 |
| Hows, J | 1 |
| Juvin, ME | 1 |
| Baron, DI | 1 |
| Voorn, GP | 1 |
| Thompson, J | 1 |
| Goessens, WH | 1 |
| Schmal-Bauer, WC | 1 |
| Broeders, PH | 1 |
| Michel, MF | 1 |
| Whitman, MS | 1 |
| Pitsakis, PG | 2 |
| Zausner, A | 1 |
| Livornese, LL | 1 |
| Osborne, AJ | 1 |
| Johnson, CC | 1 |
| Levison, ME | 2 |
| McDonald, GR | 1 |
| Anderson, MD | 1 |
| Miller, LK | 1 |
| Zaman, MM | 1 |
| Heldman, AW | 1 |
| Hartert, TV | 1 |
| Ray, SC | 1 |
| Daoud, EG | 1 |
| Kowalski, TE | 1 |
| Pompili, VJ | 1 |
| Sisson, SD | 1 |
| Tidmore, WC | 1 |
| vom Eigen, KA | 1 |
| Goodman, SN | 1 |
| Lietman, PS | 1 |
| Petty, BG | 1 |
| Flexner, C | 1 |
| Vijayvargiya, R | 1 |
| Veis, JH | 1 |
| Babinchak, TJ | 1 |
| Lambert, M | 1 |
| Boland, B | 1 |
| Coppieters, S | 1 |
| Horsmans, Y | 1 |
| Brown, NM | 1 |
| Zollman, CE | 1 |
| Martin, RP | 1 |
| Millar, MR | 1 |
| Mani, V | 1 |
| Cartwright, K | 1 |
| Dooley, J | 1 |
| Swarbrick, E | 1 |
| Fairclough, P | 1 |
| Oakley, C | 1 |
| Nettles, RE | 1 |
| Sexton, DJ | 1 |
| Rambaldi, M | 1 |
| Ambrosone, L | 1 |
| Migliaresi, S | 1 |
| Rambaldi, A | 1 |
| Goerre, S | 1 |
| Malinverni, R | 2 |
| Aeschbacher, BC | 1 |
| Marchetti, O | 1 |
| Kim, YS | 1 |
| Liu, Q | 1 |
| Chow, LL | 1 |
| Chambers, HF | 3 |
| Täuber, MG | 1 |
| Abril, V | 1 |
| Ortega, E | 1 |
| Segarra, P | 1 |
| Fraile, T | 1 |
| Caldelari, I | 1 |
| Lu, PL | 1 |
| Hsueh, PR | 1 |
| Hung, CC | 1 |
| Teng, LJ | 1 |
| Jang, TN | 1 |
| Luh, KT | 1 |
| Hershberger, E | 1 |
| Coyle, EA | 1 |
| Kaatz, GW | 6 |
| Zervos, MJ | 1 |
| Rybak, MJ | 4 |
| Butkevich, OM | 1 |
| Vinogradova, TL | 1 |
| Berrington, AW | 1 |
| Perry, JD | 1 |
| Gould, FK | 1 |
| Wiadrowski, TP | 1 |
| Reid, CM | 1 |
| Keller, LS | 1 |
| Sanders, P | 1 |
| Shaw, D | 1 |
| Brown, MA | 1 |
| Que, YA | 1 |
| Rottman, M | 1 |
| Hanau-Berçot, B | 1 |
| Fiszbin, M | 1 |
| Raskine, L | 1 |
| Gravisse, J | 1 |
| Caulin, C | 1 |
| Sanson-Le Pors, MJ | 1 |
| Uzun, O | 1 |
| Akalin, HE | 1 |
| Unal, S | 1 |
| Demircin, M | 1 |
| Yorgancioglu, AC | 1 |
| Ugurlu, B | 1 |
| Seo, SM | 3 |
| Lamp, KC | 1 |
| Bailey, EM | 1 |
| Westh, H | 1 |
| Frimodt-Møller, N | 1 |
| Gutschik, E | 1 |
| Bangsborg, J | 1 |
| Dawson, SJ | 1 |
| White, LA | 1 |
| Sacher, HL | 1 |
| Miller, WC | 1 |
| Landau, SW | 1 |
| Sacher, ML | 1 |
| Dixon, WA | 1 |
| Dietrich, KA | 1 |
| Tebas, P | 1 |
| Martinez Ruiz, R | 1 |
| Roman, F | 1 |
| Mendaza, P | 1 |
| Rodriguez Diaz, JC | 1 |
| Daza, R | 1 |
| de Letona, JM | 1 |
| Wright, C | 1 |
| Glover, SC | 1 |
| Ena, J | 1 |
| Amador, C | 1 |
| Parras, F | 1 |
| Bouza, E | 1 |
| Barnass, S | 1 |
| Holland, K | 1 |
| Tabaqchali, S | 1 |
| Santiago, M | 1 |
| Chocarro, A | 1 |
| Chaves, F | 1 |
| Sánchez-Zaballos, I | 1 |
| McWhinney, PH | 1 |
| Choo, PW | 1 |
| Gantz, NM | 1 |
| Rouse, MS | 2 |
| Wilcox, RM | 1 |
| Henry, NK | 2 |
| Steckelberg, JM | 1 |
| Wilson, WR | 2 |
| Yebra, M | 1 |
| Ortigosa, J | 1 |
| Albarrán, F | 1 |
| Crespo, MG | 1 |
| Barriere, SL | 4 |
| Albrecht, LM | 2 |
| Dworkin, RJ | 1 |
| Lee, BL | 1 |
| Sande, MA | 3 |
| Andriole, VT | 1 |
| Strunk, RW | 1 |
| Gratz, JC | 1 |
| Maserati, R | 1 |
| Scheld, WM | 1 |
| Ingerman, MJ | 1 |
| Rosenberg, AF | 1 |
| Bayer, AS | 3 |
| Blomquist, IK | 2 |
| Kim, KS | 2 |
| Daikos, GL | 1 |
| Kathpalia, SB | 1 |
| Lolans, VT | 1 |
| Jackson, GG | 1 |
| Fosslien, E | 1 |
| Boscia, JA | 2 |
| Kobasa, WD | 2 |
| Kaye, D | 2 |
| Fernandez-Guerrero, M | 2 |
| Rouse, M | 1 |
| Henry, N | 1 |
| Wilson, W | 1 |
| Breuer, J | 1 |
| Bragman, SG | 1 |
| Sahatlevan, MD | 1 |
| Philpott-Howard, JN | 1 |
| Casewell, MW | 1 |
| Schaberg, DR | 2 |
| Fekety, R | 2 |
| Lindsay, P | 1 |
| Yih, J | 1 |
| Hirano, L | 1 |
| Lee, D | 1 |
| Brooks-Fournier, RA | 1 |
| Gerberding, JL | 1 |
| Geraci, JE | 1 |
| Perronne, CM | 1 |
| Carpenter, TC | 1 |
| Hackbarth, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Partial Oral Antimicrobial Versus Intravenous Antimicrobial Therapy to Treat Infective Endocarditis in People Who Inject Drugs[NCT04544306] | 50 participants (Anticipated) | Interventional | 2021-06-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for ciprofloxacin and Endocarditis, Bacterial
| Article | Year |
|---|---|
Infective endocarditis caused by Salmonella enteritidis in a dialysis patient: a case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Female; Humans; Re | 2009 |
[Infection by Coxiella burnetii (Q fever)].
Topics: Animals; Animals, Domestic; Antibodies, Bacterial; Ciprofloxacin; Coxiella burnetii; DNA, Bacterial; | 2010 |
First case of Q fever endocarditis in Croatia and a short review.
Topics: Aged; Ciprofloxacin; Doxycycline; Echocardiography; Endocarditis, Bacterial; Humans; Hydroxychloroqu | 2010 |
Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Endocarditis, Bacterial; Heart Valve Prosthesi | 2002 |
[Endocarditis due to Bartonella spp. Three new clinical cases and Spanish literature review].
Topics: Actinobacillus Infections; Adult; Aged; Aggregatibacter actinomycetemcomitans; Alcoholism; Animals; | 2006 |
Monotherapy versus combination therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cellulit | 2006 |
1 trial available for ciprofloxacin and Endocarditis, Bacterial
| Article | Year |
|---|---|
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercul | 1996 |
91 other studies available for ciprofloxacin and Endocarditis, Bacterial
| Article | Year |
|---|---|
A complicated prosthetic valve endocarditis due to methicillin resistant Staphylococci treated with linezolid and ciprofloxacin: a case report.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valv | 2017 |
[Spondylodiscitis associated to Neisseria sicca endocarditis].
Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Ceftriaxone; Ciprofloxacin; Discitis; Endocarditis, Bacte | 2013 |
Successful oral ciprofloxacin therapy of Neisseria elongata endocarditis.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Endocarditis, Bacterial; Humans; Male; Neisseria elonga | 2014 |
Phage-mediated dispersal of biofilm and distribution of bacterial virulence genes is induced by quorum sensing.
Topics: Animals; Biofilms; Caco-2 Cells; Ciprofloxacin; Endocarditis, Bacterial; Enterococcus faecalis; Fema | 2015 |
Kingella kingae Sequence Type 25 Causing Endocarditis with Multiple and Severe Cerebral Complications.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteremia; Cerebrospinal Fluid; Ciprofloxacin; Drug Combination | 2016 |
Neisseria elongata subsp elongata infective endocarditis following endurance exercise.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Echocardiography; Endocarditis, Bacterial; | 2015 |
Nocardia Bacteremia and Endocarditis in a Patient With a Sulfa Allergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Hypersensitivity; Dyspnea; Endocard | 2016 |
First case of Pasteurella multocida endocarditis of the tricuspid valve: a favorable outcome following medical treatment.
Topics: Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Blood; Ciprofloxacin; Culture Media; Echocardi | 2009 |
Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.
Topics: Adult; Aortic Valve; Chromobacterium; Ciprofloxacin; Drug Therapy, Combination; Echocardiography, Tr | 2009 |
Antibiotic prophylaxis in gastrointestinal endoscopy.
Topics: Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Endocarditis, Bacterial; Endoscopy, Gastrointesti | 2009 |
Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.
Topics: Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bact | 2009 |
Ruptured pulmonary artery caused by isolated pulmonary valve endocarditis: case report.
Topics: Aged; Aneurysm, Ruptured; Anti-Bacterial Agents; Anti-Infective Agents; Carcinoma, Hepatocellular; C | 2010 |
Endocarditis after urinary tract infection.
Topics: Aged; Anti-Infective Agents; Aortic Valve; Ciprofloxacin; Diagnosis, Differential; Echocardiography, | 2002 |
Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton).
Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Child; Child, Preschool; | 2002 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; En | 2004 |
Response to . . . successful use of oral linezolide.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Ciprofloxacin; Endocarditis, Bacterial; Humans; M | 2004 |
A case of mitral stenosis complicated with seronegative Brucella endocarditis.
Topics: Adult; Brucella melitensis; Brucellosis; Ciprofloxacin; Combined Modality Therapy; Doxycycline; Drug | 2004 |
Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies.
Topics: Ampicillin; Antigens, Human Platelet; Aortic Valve Stenosis; Autoantibodies; Autoimmune Diseases; Ba | 2004 |
["Actinobacillus and Haemophilus parainfluenzae infective endocarditis: two case reports"].
Topics: Actinobacillus Infections; Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Therapy, C | 2004 |
In vivo testing of an infection-resistant annuloplasty ring.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Heart Valve Prosthesis; Mate | 2006 |
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
Topics: beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Femal | 2006 |
Intraaortic vegetations and infective endocarditis.
Topics: Anti-Infective Agents; Aorta, Thoracic; Ciprofloxacin; Drug Combinations; Echocardiography, Transeso | 2007 |
Endocarditis due to Salmonella enterica subsp. arizonae in a patient with sickle cell disease: a case report and review of the literature.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Echocardiography; Endocardit | 2007 |
Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gr | 1994 |
[Successfully treated Salmonella enteritidis endocarditis].
Topics: Brain Diseases; Cefuroxime; Ciprofloxacin; Echocardiography; Endocarditis, Bacterial; Hematoma; Huma | 1995 |
Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis.
Topics: Adult; Ampicillin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditi | 1995 |
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.
Topics: Animals; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacteria | 1995 |
[Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].
Topics: Animals; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation; Endocarditis | 1995 |
Antibacterial efficacy of ciprofloxacin in a case of endocarditis due to Cardiobacterium hominis.
Topics: Adult; Bacteria, Anaerobic; Blood Bactericidal Activity; Ciprofloxacin; Endocarditis, Bacterial; Gra | 1994 |
Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma.
Topics: Azlocillin; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Gentamicins; | 1994 |
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Endocarditis, Bacterial; Female; Humans; Infusions, | 1994 |
Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
Topics: Animals; Ciprofloxacin; Cloxacillin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Hu | 1994 |
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; D | 1993 |
Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
Topics: Aged; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus fa | 1993 |
Endocarditis due to Neisseria mucosa.
Topics: Aged; Ciprofloxacin; Endocarditis, Bacterial; Humans; Male; Neisseria; Neisseriaceae Infections | 1993 |
Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, | 1995 |
Antibiotic-resistant endocarditis in a hemodialysis patient.
Topics: Ampicillin; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug T | 1996 |
Oral ciprofloxacin therapy for prosthetic valve endocarditis due to Actinobacillus actinomycetemcomitans.
Topics: Actinobacillus Infections; Administration, Oral; Aged; Aggregatibacter actinomycetemcomitans; Anti-I | 1995 |
[Asymptomatic increase of pancreatic enzymes associated with ciprofloxacin therapy].
Topics: Alanine Transaminase; Amylases; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Esche | 1996 |
Ciprofloxacin treatment of bacterial endocarditis involving prosthetic material after cardiac surgery.
Topics: Anti-Infective Agents; Blood Vessel Prosthesis; Child; Child, Preschool; Ciprofloxacin; Drug Therapy | 1997 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophyla | 1997 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxa | 1997 |
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, C | 1997 |
Combination of co-trimoxazole and ciprofloxacin as therapy of a patient with infective endocarditis caused by an enterococcus highly resistant to gentamicin.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; | 1997 |
Successful conservative treatment of nontyphoid salmonella endocarditis involving a bioprosthetic valve.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Echocardiography, Transesophageal; Endocarditis, Bacteri | 1998 |
Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; | 1998 |
Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Fluoroquinolones; Heart; Met | 1998 |
[Late recurrence of endocarditis caused by Coxiella burnetii following prosthetic valve substitution and prolonged antibiotic treatment].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Coxiella burnetii; Doxycycline; Endocar | 1999 |
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial | 1999 |
Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis.
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Endocar | 2000 |
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations.
Topics: Animal Testing Alternatives; Animals; Anti-Infective Agents; Blood Platelets; Cattle; Ciprofloxacin; | 2000 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infect | 2000 |
Bactericidal activity of moxifloxacin against Staphylococcus aureus.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Endocarditis, Bacterial; Fluoroquinolones; Huma | 2001 |
Drug-induced linear IgA bullous disease following antibiotics.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Arm; Ciprofloxacin; Drug Eruptions; Endocarditis | 2001 |
Salmonella prosthetic valve (mechanical) endocarditis managed conservatively.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Female; Hear | 2001 |
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; Dru | 2001 |
Diagnosis of Actinobacillus actinomycetemcomitans infective endocarditis after steadily negative blood cultures.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Anti-Infective Agents; Ceft | 2002 |
Long-term oral ciprofloxacin in the treatment of prosthetic valve endocarditis due to Pseudomonas aeruginosa.
Topics: Administration, Oral; Adult; Aortic Valve; Ciprofloxacin; Drug Administration Schedule; Endocarditis | 1992 |
CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; | 1992 |
Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Synergism; Endocarditis, Bacterial; Haemoph | 1992 |
Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin.
Topics: Adult; Cefotaxime; Ciprofloxacin; Endocarditis, Bacterial; Haemophilus Infections; Humans; Male; Mic | 1992 |
Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy.
Topics: Adult; Ampicillin; beta-Lactamases; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Endoca | 1991 |
Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis.
Topics: Adult; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Male; Rifampin; S | 1991 |
Tricuspid valve infective endocarditis and pulmonary sepsis due to Erysipelothrix rhusiopathiae successfully treated with high doses of ciprofloxacin but complicated by gynaecomastia.
Topics: Ciprofloxacin; Endocarditis, Bacterial; Erysipelothrix Infections; Gynecomastia; Humans; Male; Middl | 1991 |
Ciprofloxacin as an effective antibacterial agent in serratia endocarditis.
Topics: Adult; Ciprofloxacin; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Inject | 1991 |
Vancomycin-resistant Corynebacterium species causing prosthetic valve endocarditis successfully treated with imipenem and ciprofloxacin.
Topics: Adult; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Endoc | 1991 |
[Ciprofloxacin in the treatment of a case of endocarditis caused by Eikenella corrodens].
Topics: Aged; Bacteroides Infections; Ciprofloxacin; Eikenella corrodens; Endocarditis, Bacterial; Female; H | 1990 |
Treatment failure with teicoplanin and response to oral antibiotic regimens.
Topics: Administration, Oral; Adult; Ciprofloxacin; Endocarditis, Bacterial; Female; Glycopeptides; Humans; | 1990 |
Reversible leukopenia related to ciprofloxacin therapy.
Topics: Ciprofloxacin; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Leukopenia; Middle A | 1990 |
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Ciprofloxacin; Endocarditis, Bacterial; Humans; Methicillin; Penicillin Resistance; Rabbits | 1990 |
Ciprofloxacin in a case of Q fever endocarditis.
Topics: Ciprofloxacin; Endocarditis, Bacterial; Humans; Male; Middle Aged; Q Fever | 1990 |
Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Fleroxacin; Male; Methi | 1989 |
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.
Topics: Adult; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; End | 1989 |
An update on the efficacy of ciprofloxacin in animal models of infection.
Topics: Abscess; Animals; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Endocarditis, Bacteri | 1989 |
Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacteri | 1989 |
Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
Topics: Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Microbial Se | 1985 |
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.
Topics: Animals; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Endocardit | 1986 |
Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
Topics: Abscess; Animals; Anti-Infective Agents; Aortic Valve; Azlocillin; Ciprofloxacin; Drug Therapy, Comb | 1986 |
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Fe | 1986 |
Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Drug Administration Schedule; E | 1988 |
Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cefazolin; Ciprofloxacin; Endocarditis, Bacter | 1988 |
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Imi | 1988 |
The possible role of ciprofloxacin in the treatment of endocarditis caused by Pseudomonas aeruginosa.
Topics: Aged; Ciprofloxacin; Drug Combinations; Endocarditis, Bacterial; Female; Gentamicins; Humans; Penici | 1988 |
The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacte | 1987 |
Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Ente | 1987 |
Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.
Topics: Animals; Aortic Valve; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacteri | 1986 |
Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
Topics: Animals; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Endocarditis, Bacteria | 1987 |
In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Pen | 1987 |
Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
Topics: Aminocoumarins; Animals; Ciprofloxacin; Cloxacillin; Coumarins; Drug Evaluation, Preclinical; Drug T | 1987 |
Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
Topics: Animals; Ciprofloxacin; Endocarditis, Bacterial; Kinetics; Methicillin; Penicillin Resistance; Rabbi | 1986 |
Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Kinetics; Methicillin | 1987 |